BridgeMD
New treatment option for Neonatal Death
Official title CHV-NEO: Community-based Digital Communication to Support Neonatal Health
ClinicalTrials.gov ID: NCT05187897
What this study is testing
- What it's testing
- Neonatal mortality (defined as death in the first 28 days of life) remains unacceptably high in sub-Sarahan Africa. The concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate means that expanding mothers' access to timely information and support during this period is critical to reducing neonatal mortality.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Pregnant
- 26-36 weeks gestation
- Daily access to a mobile phone (own or shared)
- Willing to receive SMS
- Age ≥14 years
You likely can't join if
- participating in another study
- previously participated in this study
See the full eligibility criteria
- Pregnant
- 26-36 weeks gestation
- Daily access to a mobile phone (own or shared)
- Willing to receive SMS
- Age ≥14 years
- Able to read and respond to text messages in English, Kiswahili or Luo, or have someone in the household who can help
- Receiving antenatal care at study facility
- Plan to be in the area for at least 3 months postpartum
- participating in another study
- previously participated in this study
The study team makes the final eligibility decision.
Where it's taking place
- Kisumu, Kenya
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 14 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kisumu, Kenya. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.